728 related articles for article (PubMed ID: 6086696)
1. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
[TBL] [Abstract][Full Text] [Related]
2. Are disturbances in opioid and adrenergic systems involved in the hormonal dysfunction of anorexia nervosa?
Baranowska B
Psychoneuroendocrinology; 1990; 15(5-6):371-9. PubMed ID: 2129311
[TBL] [Abstract][Full Text] [Related]
3. Opioid effects on plasma concentrations of luteinizing hormone and prolactin in the adult male rhesus monkey.
Gilbeau PM; Almirez RG; Holaday JW; Smith CG
J Clin Endocrinol Metab; 1985 Feb; 60(2):299-305. PubMed ID: 2981242
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade.
Barbarino A; De Marinis L; Tofani A; Della Casa S; D'Amico C; Mancini A; Corsello SM; Sciuto R; Barini A
J Clin Endocrinol Metab; 1989 Mar; 68(3):523-8. PubMed ID: 2493035
[TBL] [Abstract][Full Text] [Related]
5. [Changes in LH, FSH, PRL and estradiol after perfusion with naloxone in normal and amenorrheic women].
Gandar R; Armani J
J Gynecol Obstet Biol Reprod (Paris); 1984; 13(7):765-9. PubMed ID: 6441816
[TBL] [Abstract][Full Text] [Related]
6. The effects of opioid blockade and GnRH administration upon luteinizing hormone secretion in patients with anorexia nervosa during the stages of weight loss and weight recovery.
García-Rubí E; Vazquez-Alemán D; Mendez JP; Salinas JL; Garza-Flores J; Ponce-de-León S; Perez-Palacios G; Ulloa-Aguirre A
Clin Endocrinol (Oxf); 1992 Dec; 37(6):520-8. PubMed ID: 1286522
[TBL] [Abstract][Full Text] [Related]
7. Endogenous opioid blockade and gonadotropin secretion: role of pulsatile luteinizing hormone-releasing hormone administration in anorexia nervosa and weight loss amenorrhea.
Giusti M; Torre R; Traverso L; Cavagnaro P; Attanasio R; Giordano G
Fertil Steril; 1988 May; 49(5):797-801. PubMed ID: 3129313
[TBL] [Abstract][Full Text] [Related]
8. Role of endogenous opioid peptides in the initiation of the midcycle luteinizing hormone surge in normal cycling women.
Rossmanith WG; Mortola JF; Yen SS
J Clin Endocrinol Metab; 1988 Oct; 67(4):695-700. PubMed ID: 3138276
[TBL] [Abstract][Full Text] [Related]
9. The effect of naloxone on ATCH and beta-endorphin in patients with Cushing's disease.
Baranowska B; Dorobek W; Misiorowski W; Jeske W; Abdel-Fattah MH
Acta Endocrinol (Copenh); 1985 Oct; 110(2):170-5. PubMed ID: 2998130
[TBL] [Abstract][Full Text] [Related]
10. Steroids and neuroendocrine function in anorexia nervosa.
Casanueva FF; Borras CG; Burguera B; Muruais C; Fernández M; Devesa J
J Steroid Biochem; 1987; 27(1-3):635-40. PubMed ID: 3121928
[TBL] [Abstract][Full Text] [Related]
11. Hyperprolactinemia decreases the luteinizing hormone-releasing hormone concentration in pituitary portal plasma: a possible role for beta-endorphin as a mediator.
Sarkar DK; Yen SS
Endocrinology; 1985 May; 116(5):2080-4. PubMed ID: 3157564
[TBL] [Abstract][Full Text] [Related]
12. Delayed pituitary hormone response to LRF and TRF in patients with anorexia nervosa and with secondary amenorrhea associated with simple weight loss.
Vigersky RA; Loriaux DL; Andersen AE; Mecklenburg RS; Vaitukaitis JL
J Clin Endocrinol Metab; 1976 Oct; 43(4):893-900. PubMed ID: 824302
[TBL] [Abstract][Full Text] [Related]
13. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
Quigley ME; Sheehan KL; Casper RF; Yen SS
J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
[TBL] [Abstract][Full Text] [Related]
14. Endogenous opioid peptides modulate the effect of corticotropin-releasing factor on gonadotropin release in the primate.
Gindoff PR; Ferin M
Endocrinology; 1987 Sep; 121(3):837-42. PubMed ID: 3113919
[TBL] [Abstract][Full Text] [Related]
15. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
[TBL] [Abstract][Full Text] [Related]
16. Evidence for an increased opioid inhibition of luteinizing hormone secretion in hyperprolactinemic patients with pituitary microadenoma.
Quigley ME; Sheehan KL; Casper RF; Yen SS
J Clin Endocrinol Metab; 1980 Mar; 50(3):427-30. PubMed ID: 7358828
[TBL] [Abstract][Full Text] [Related]
17. The effect of D-Trp6-LRH upon secretion of gonadotrophin--a possible therapeutic application in anorexia nervosa.
Zgliczyński S; Baranowska B; Jeske W; Niewiadomska A; Rozbicka G; Schally AV
Acta Endocrinol (Copenh); 1984 Feb; 105(2):161-6. PubMed ID: 6229967
[TBL] [Abstract][Full Text] [Related]
18. Naloxone stimulation of luteinizing hormone secretion in the female monkey: influence of endocrine and experimental conditions.
Van Vugt DA; Bakst G; Dyrenfurth I; Ferin M
Endocrinology; 1983 Nov; 113(5):1858-64. PubMed ID: 6414806
[TBL] [Abstract][Full Text] [Related]
19. The disappearance of opioidergic regulation of gonadotropin secretion in postmenopausal women.
Reid RL; Quigley ME; Yen SS
J Clin Endocrinol Metab; 1983 Dec; 57(6):1107-10. PubMed ID: 6313728
[TBL] [Abstract][Full Text] [Related]
20. The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle.
Snowden EU; Khan-Dawood FS; Dawood MY
J Clin Endocrinol Metab; 1984 Aug; 59(2):298-302. PubMed ID: 6330154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
